Development and Evaluation of Lorazepam Microemulsions for Parenteral Delivery

被引：27

作者：

Kale, Amit A. ^{[1
]}

Patravale, Vandana B. ^{[1
]}

机构：

[1] Inst Chem Technol, Dept Pharmaceut Sci & Technol, Bombay 400019, Maharashtra, India

来源：

AAPS PHARMSCITECH | 2008年 / 9卷 / 03期

关键词：

capmul MCM; lorazepam; parenteral microemulsion; poor aqueous solubility;

D O I：

10.1208/s12249-008-9131-z

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The objective of this investigation was to develop lorazepam (LZM) microemulsions as an alternative to the conventional cosolvent based formulation. Solubility of LZM in various oils and Tween 80 was determined. The ternary diagram was plotted to identify area of microemulsion existence and a suitable composition was identified to achieve desired LZM concentration. The LZM microemulsions were evaluated for compatibility with parenteral fluids, globule size, in vitro hemolysis and stability of LZM. Capmul MCM demonstrated highest solubilizing potential for LZM and was used as an oily phase. LZM microemulsions were compatible with parenteral dilution fluids and exhibited mean globule size less than 200 nm. The in vitro hemolysis studies indicated that microemulsions were well tolerated by erythrocytes. The LZM microemulsions containing amino acids exhibited good physical and chemical stability when subjected to refrigeration for 6 months.

引用

页码：966 / 971

页数：6

共 15 条

[1] Microemulsions are membrane-active, antimicrobial, self-preserving systems [J].

Al-Adham, ISI ;

Khalil, E ;

Al-Hmoud, ND ;

Kierans, M ;

Collier, PJ .

JOURNAL OF APPLIED MICROBIOLOGY, 2000, 89 (01) :32-39

[2] POSTOPERATIVE INFECTIONS TRACED TO CONTAMINATION OF AN INTRAVENOUS ANESTHETIC, PROPOFOL [J].

BENNETT, SN ;

MCNEIL, MM ;

BLAND, LA ;

ARDUINO, MJ ;

VILLARINO, ME ;

PERROTTA, DM ;

BURWEN, DR ;

WELBEL, SF ;

PEGUES, DA ;

STROUD, L ;

ZEITZ, PS ;

JARVIS, WR .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (03) :147-154

[3]

Corswant CV, 1997, LANGMUIR, V13, P5061

[4] Parenteral microemulsions: An overview [J].

Date, Abhijit A. ;

Nagarsenker, M. S. .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :19-30

[5]

Fu X, 2001, COLLOID SURFACE A, V179, P1

[6] Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use [J].

Holvoet, C ;

Vander Heyden, Y ;

Plaizier-Vercammen, J .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (06) :567-575

[7]

JUMMA M, 1999, PHARM ACTA HELV, V73, P293

[8] Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions [J].

Li, P ;

Ghosh, A ;

Wagner, RF ;

Krill, S ;

Joshi, YM ;

Serajuddin, ATM .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 288 (01) :27-34

[9] Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection [J].

Medina, J ;

Salvadó, A ;

del Pozo, A .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 216 (1-2) :1-8

[10]

NELSON DL, 2000, LEHNINGER PRINCIPLES, P426

← 1 2 →